As filed with the Securities and Exchange Commission on February 1, 2010

 

Registration No. 333-          

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

Acorda Therapeutics, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

2006 Employee Incentive Plan

(Full Title of the Plan)

 

Ron Cohen, M.D.

Chief Executive Officer

15 Skyline Drive

Hawthorne, New York 10532

(Name and Address of Agent For Service)

 

(914) 347-4300

(Telephone Number, Including Area Code, of Agent For Service)

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer  x		Accelerated  o
Non-Accelerated Filer  o (Do not check if a smaller reporting company)		Smaller Reporting Company  o

 

CALCULATION OF REGISTRATION FEE

 

Title of Securities to be Registered		Amount to be Registered(1)		Proposed Maximum Offering Price Per Share			Proposed Maximum Aggregate Offering Price			Amount of Registration Fee
2006 Employee Incentive Plan, Common Stock, $0.001 par value per share		1,525,554 shares		$	27.80	(2)	$	42,410,401	(2)	$	3,024

 

(1)  In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(2)  Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h) and 457(c) of the Securities Act of 1933, as amended. The price per share and aggregate offering price are calculated on the basis of the average of the high and low prices of the Registrant’s common stock on January 29, 2010, as reported on the NASDAQ Global Market.

 

 

 

EXPLANATORY NOTE

 

This Registration Statement on Form S-8 is being filed for the purpose of registering an aggregate of 1,525,554 shares of common stock of the Registrant to be issued pursuant to the Registrant’s 2006 Employee Incentive Plan (the “Plan”). The shares being registered hereunder represent the number of shares by which the Plan was automatically increased on January 1, 2010, as provided by the terms of the Plan.

 

Item 3.    INCORPORATION BY REFERENCE

 

Pursuant to General Instruction E to Form S-8, the contents of the Registrant’s Registration Statements on Form S-8 (File Nos. 333-131846, 333-149726 and 333-158085), filed with the Securities and Exchange Commission on February 14, 2006, March 14, 2008 and March 18, 2009, respectively, are incorporated by reference.

 

Item 8.    EXHIBITS.

 

The Exhibit Index immediately preceding the exhibits is incorporated herein by reference.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hawthorne, State of New York, on February 1, 2010.

 

	ACORDA THERAPEUTICS, INC.
	By:	/s/ Ron Cohen, M.D.
		Ron Cohen, M.D.
		President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.

 

Name		Title		Date
/s/ Ron Cohen, M.D.		President, Chief Executive Officer and		February 1, 2010
Ron Cohen, M.D.		Director (Principal Executive Officer)
/s/ David Lawrence, M.B.A.		Chief Financial Officer (Principal Financial Officer		February 1, 2010
David Lawrence, M.B.A.		and Principal Accounting Officer)

 

POWER OF ATTORNEY

 

We, the undersigned officers and directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signatures		Title		Date
/s/ Barry Greene		Director		February 1, 2010
Barry Greene
/s/ John Kelley		Director		February 1, 2010
John Kelley
/s/ Sandra Panem, Ph.D.		Director		January 4, 2010
Sandra Panem, Ph.D.
/s/ Lorin J. Randall		Director		February 1, 2010
Lorin J. Randall
/s/ Steven M. Rauscher		Director		February 1, 2010
Steven M. Rauscher

 

3

 

/s/ Ian F. Smith		Director		February 1, 2010
Ian F. Smith
/s/ Wise Young, Ph.D., M.D.		Director		January 21, 2010
Wise Young, Ph.D., M.D.

 

4

 

INDEX TO EXHIBITS

 

Number		Description
5.1		Opinion of Covington & Burling LLP, counsel to the Registrant
23.1		Consent of Covington & Burling LLP (included in Exhibit 5.1)
23.2		Consent of KPMG LLP
24.1		Power of Attorney of all directors of the board of directors of the Registrant except Sandra Panem (included on the signature pages of this registration statement)
24.2		Power of Attorney of Sandra Panem

 

5